Meningitis UK funds lifesaving research into finding a vaccine to eradicate meningitis.
Although there are vaccines to protect against some forms of meningitis, there is still no vaccine to protect against all strains, including the most common in the UK - Meningitis B, which causes almost 90% of all cases and is most prevalent in children under the age of five.
Meningitis UK has a sole focus - to find a vaccine to protect against all forms of meningitis and associated diseases.
Great advances have been made in the fight against meningitis over the last 20 years and we believe more than ever that with continued support and persistent research, our vision can be achieved.
We receive no government funding, so your support is crucial in enabling us to continue our vital work to eradicate these diseases and the subsequent devastation they cause.
Meningitis UK's 'Search 4 a Vaccine Campaign' aims to raise £7 million over the next seven years to help fund cutting-edge research to develop a vaccine against Meningitis B, which causes almost 90% of cases in the UK and for which there is currently no vaccine.
Meningitis UK launch Big Bug Hunt for 0-5 year olds
Are you a play leader in a play-group or nursery? Are you looking for new ways to keep the little ones entertained and happy, while meeting the Early Years Foundation Stage goals? Then the Big Bug Hunt, running throughout September and October 2008 is the event for you. Designed to appeal to pre-school children's love of bugs - and anything bug related - our Cheeky Bug, like the Meningitis bug, needs to be found. And the best way of finding him is via the Big Bug Hunt. Registration is open now! Go to our dedicated site www.bigbughunt.org to find out more about how you can help us in our search for a vaccine, while having fun with your under-5s.
Put on your glad rags for Meningitis UK
Step into your ball gown or dinner jacket and attend one of our forthcoming charity balls. Tickets are selling like hot cakes, so get in touch now!
Meningitis UK's stance on Phase II data for Meningitis B vaccine
The presentation of Phase II data for a vaccine for Meningitis B, which is being developed by Novartis, is welcomed by Meningitis UK. However, there is still a long way to go in the fight against this killer disease, and it is vital that research into Meningitis B continues. For our full response, go to our news release. Chief Executive Steve Dayman is quoted on the BBC online; to see the full report go to the BBC Health pages. Our Head of Development, Kate Rowland, is also featured on Channel 5 news.
MeningitisUK · Registered Charity No.1076774
